# Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)

> **NCT01328769** · PHASE4 · COMPLETED · sponsor: **Paul N. Hopkins** · enrollment: 49 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Febuxostat
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01328769
- **Lead sponsor:** Paul N. Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2013-09
- **Final completion:** 2014-01
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2015-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01328769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01328769, "Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT01328769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*